These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 21438910

  • 1. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW, Lautner MH, Schütze A, Taubert H, Schubert J, Bilkenroth U.
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [Abstract] [Full Text] [Related]

  • 2. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, Kuo MY, Chiang CP.
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X, Yang D, Hu J, Hao X, Gao J, Mao Z.
    Anticancer Res; 2008 Jan; 28(3A):1659-66. PubMed ID: 18630523
    [Abstract] [Full Text] [Related]

  • 4. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
    Lidgren A, Bergh A, Grankvist K, Rasmuson T, Ljungberg B.
    BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
    [Abstract] [Full Text] [Related]

  • 5. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC, Qiu ZJ, Liu J, Sun J, Jiang T, Huang KJ, Yao M, Huang C.
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [Abstract] [Full Text] [Related]

  • 6. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
    Dellas K, Bache M, Pigorsch SU, Taubert H, Kappler M, Holzapfel D, Zorn E, Holzhausen HJ, Haensgen G.
    Strahlenther Onkol; 2008 Mar 15; 184(3):169-74. PubMed ID: 18330514
    [Abstract] [Full Text] [Related]

  • 8. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
    Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B, Gamallo C.
    Ann Surg Oncol; 2009 Aug 15; 16(8):2351-8. PubMed ID: 19449077
    [Abstract] [Full Text] [Related]

  • 9. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
    XU O, LI XM, WANG MX, QU YT, LU XY, SHAN CG, SUN QJ.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr 15; 47(4):330-3. PubMed ID: 22800355
    [Abstract] [Full Text] [Related]

  • 10. Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients.
    Eckert AW, Lautner MH, Taubert H, Schubert J, Bilkenroth U.
    Oncol Rep; 2008 Dec 15; 20(6):1381-5. PubMed ID: 19020718
    [Abstract] [Full Text] [Related]

  • 11. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH, Karaveli S, Simsek T, Erdogan G, Pestereli E.
    Gynecol Oncol; 2008 Mar 15; 108(3):603-8. PubMed ID: 18191183
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH.
    J Clin Pathol; 2008 May 15; 61(5):658-64. PubMed ID: 17908805
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.
    Kunkel M, Moergel M, Stockinger M, Jeong JH, Fritz G, Lehr HA, Whiteside TL.
    Oral Oncol; 2007 Sep 15; 43(8):796-803. PubMed ID: 17207657
    [Abstract] [Full Text] [Related]

  • 14. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
    Ishikawa H, Sakurai H, Hasegawa M, Mitsuhashi N, Takahashi M, Masuda N, Nakajima M, Kitamoto Y, Saitoh J, Nakano T.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):513-21. PubMed ID: 15380586
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT, Cai ZM, Li NC, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 25; 86(28):1970-4. PubMed ID: 17064593
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
    Naruse T, Kawasaki G, Yanamoto S, Mizuno A, Umeda M.
    Anticancer Res; 2011 Dec 25; 31(12):4429-37. PubMed ID: 22199311
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
    Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W, Whiteside TL.
    Cancer; 2003 Feb 15; 97(4):1015-24. PubMed ID: 12569601
    [Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
    Korkeila EA, Sundström J, Pyrhönen S, Syrjänen K.
    Anticancer Res; 2011 Dec 15; 31(12):4529-35. PubMed ID: 22199327
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
    Ishikawa T, Nakashiro K, Klosek SK, Goda H, Hara S, Uchida D, Hamakawa H.
    Oncol Rep; 2009 Mar 15; 21(3):707-12. PubMed ID: 19212630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.